CF6 was considerably expressed in pulmonary arteries and lung tissues from patients with NSCLC, but was limited expressed in ECs and barely detectable in normal lung tissue (Additional file 1: Figure S3), suggesting that CF6 might be both an obvious marker of impaired endothelium and a novel risk factor contributing to vascular damage. Here, ATP5PF is linked to non-small cell lung carcinoma.